By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The Innovator’s Pitch Challenge (IPC) returns in two weeks as part of Digital RESI, March 22-24. The IPC is a highly anticipated and popular feature of the virtual Digital RESI format. Representing therapeutics, medical devices, diagnostics, and digital health, finalists use the opportunity to showcase their technology to registered RESI attendees, which include over 300 active early-stage life science investors. Each company will have a dedicated landing page that includes their pitch video, slide deck, executive summary, and other marketing collateral. These companies will also be engaging in a live Q&A session with investors who have relevant expertise, which will help them prepare for future investor meetings. These sessions often lead to engaging follow-on discussions and valuable, long-term connections.
Check out each finalist below and learn more about the Digital RESI JPM winners!
- First Place: Amplified Sciences – Making a Difference One Impression at a Time
- Second Place: OncoXome – Family Matters in Fundraising
- Third Place: Prolifagen – Ascending the Steep Slope of Preclinical Fundraising
Digital RESI March 2022 IPC Finalists
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Next Phase Newsletter 
Leave a comment